Therapeutic Neovascularization – Quo vadis?
محفوظ في:
| مؤلف مشترك: | |
|---|---|
| مؤلفون آخرون: | , |
| التنسيق: | الكتروني كتاب الكتروني |
| اللغة: | English |
| منشور في: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2007.
|
| الطبعة: | 1st ed. 2007. |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1007/1-4020-5955-8 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
جدول المحتويات:
- Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease
- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis
- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction
- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword
- Pampering and Priming the Heart
- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization
- Integrative Pro-angiogenic Activation: HIF-?
- The Maturation of Vessels – A Limitation to Forced Neovascularization?
- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads
- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis
- The Biology of Embryonic and Adult Endothelial Progenitor Cells
- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin
- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth.